Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
The bisphosphonates 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid (ABP), 3-amino-1, 1-hydroxypropane-1, 1-diphosphonic acid (APD), and 1-hyroxyethane-1, 1-diphosphonic acid (EHDP) were compared for their ability to inhibit the osteoclastic resorption of bone in culture. This was achieved by measuring the effect of bisphosphonate concentration on the number of resorption pits formed and the total area of resorption. During this analysis, a new application of reflected polarized light microscopy was developed that has advantages over other microscopy techniques, including scanning electron microscopy (SEM), as applied to the analysis of resorbed bone surfaces. Based on area analysis, the bisphosphonates were effective for the range 10−7–10−8 M, with ABP about two to five times more effective than EHDP or APD. Similar data were obtained by counting the number of resorption pits but with EC50 10 times higher. At lower concentrations (10−9 M), bisphosphonates may enhance the formation of resorption pits. APD was found to be more toxic (10 times) than ABP or EHDP to osteoclasts and mononuclear cells, but toxic concentrations were at least 102 times higher than the resorption EC50. These data plus immunofluorescence, SEM, and transient incubation experiments show that it is the bisphosphonate-bone complex that directly inhibits the excavation of resorption pits by mature osteoclasts. The mechanism of action does not appear to require inhibition of osteoclast differentiation or toxic elimination of osteoclasts. Bisphosphonates, however, subtly affect the cytoskeleton of osteoclasts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bisphosphonates do not appear to suppress osteoclastogenesis (129, 140, 141)”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [129]
In the citing paper
“In contrast, bisphosphonates have a different mechanism of action that can be associated with normal or even increased osteoclast numbers despite clear antiresorptive effects (129 -138).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [129]
Citations
Cites
Izzard, C. S., & Lochner, L. R. (1976) · Journal of Cell Science · doi:10.1242/jcs.21.1.129 · Cited by 705
Seaweeds and ulcerative colitis in laboratory animals.
Marcus, R., & Watt, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90187-1 · Cited by 427
Resorption of bone by isolated rabbit osteoclasts
Chambers, T. J., Revell, P. A., Fuller, K., & Athanasou, N. A. (1984) · Journal of Cell Science · doi:10.1242/jcs.66.1.383 · Cited by 413
Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Boonekamp, P. M., van der Wee-Pals, L. J. A., LENNEP, M. V., Cw, T., & Bijvoet, O. L. (1986) · PubMed · Cited by 345
Inoué, S. (1986) · Springer eBooks · doi:10.1007/978-1-4757-6925-8 · Cited by 342
Schenk, R., Eggli, P., Fleisch, H., & Rosini, S. (1986) · Calcified Tissue International · doi:10.1007/bf02555748 · Cited by 315
Structure-activity relationships of various bisphosphonates
Shinoda, H., Adamek, G., Felix, R., Fleisch, H., Schenk, R., & Hagan, P. (1983) · Calcified Tissue International · doi:10.1007/bf02405012 · Cited by 306
TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)
Frijlink, W. B., Bijvoet, O. M., Te Velde, J., & Heynen, G. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91318-7 · Cited by 258
Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.
Elomaa, I., Blomqvist, C., Gröhn, P., Porkka, L., Kairento, A.-L., Selander, K., Lamberg-Allardt, C., & Holmström, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92755-1 · Cited by 209
Quantitative reflection contrast microscopy of living cells.
Bereiter-Hahn, J., Fox, C. H., & Thorell, B. (1979) · The Journal of cell biology · doi:10.1083/jcb.82.3.767 · Cited by 195
Cited by
Items 201–280 of 280
Ciliopathic micrognathia is caused by aberrant skeletal differentiation and remodeling
Paese, C. L. B., Brooks, E. C., Aarnio, M., & Brugmann, S. A. (2021) · Development · doi:10.1242/dev.194175 · Cited by 9
Lozano‐Carrascal, N., Salomó‐Coll, O., Hernández-Alfaro, F. J., Sa, G., Gargallo‐Albiol, J., & Calvo‐Guirado, J. L. (2017) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.21887 · Cited by 8
“Several experimental studies have demonstrated that these drugs reduce bone resorption by inhibiting the activity of mature osteoclasts and promoting their apotosis (6,7).”
BackgroundGray, A., Davies, M., & Jeffcott, L. B. (2000) · Research in Veterinary Science · doi:10.1053/rvsc.1999.0367 · Cited by 8
Engel, E., Serrano, S., Mariñoso, M. L., Lloreta, J., Ulloa, F., Nogués, X., Díez‐Pérez, A., & Abelló, J. C. (2003) · Calcified Tissue International · doi:10.1007/s00223-001-2136-1 · Cited by 8
“On the other hand, several in vitro studies [9, 10] failed to show the differences in inhibitory power on bone resorption found in vivo among the different types of bisphosphonates.”
BackgroundFleisch, H. A. (2000) · Elsevier eBooks · doi:10.1016/b978-012260371-6.50004-5 · Cited by 8
Jin, Y., Song, J., Diao, Z., Han, X. Y., & Fan, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115233 · Cited by 7
“Some researchers estimated that the average concentration of BPs at patients’ bone lesion sites was as high as 1 mM, which is much higher than the concentration of BPs needed to affect BMSCs’ morphology and suppress their activities in vitro [26,27].”
Calcium Medronate-Based Metal–Organic Frameworks as Multifunctional Biomaterials
Salcedo‐Abraira, P., Fernández-Grajera, M., Guerrero-Román, F. A., Rodríguez‐Diéguez, A., Luque-Agudo, V., González-Martín, M. L., Gallardo-Moreno, A. M., & Rojas, S. (2025) · Crystal Growth & Design · doi:10.1021/acs.cgd.4c01478 · Cited by 7
Host modulatory agents in periodontics: A step towards the future
Bhatt, A., Govila, V., & Sharma, M. (2015) · Journal of the International Clinical Dental Research Organization · doi:10.4103/2231-0754.164380 · Cited by 7
Cellular and molecular actions of bisphosphonates
Junankar, S. R., & Rogers, M. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00051-0 · Cited by 7
Bisphosphonates in the Treatment of Glucocorticoid-Induced Osteoporosis
Doga, M., Bonadonna, S., Burattin, A., Carpinteri, R., Manelli, F., & Giustina, A. (2002) · KARGER eBooks · doi:10.1159/000061082 · Cited by 7
Bone marrow cells produce soluble factors that inhibit osteoclast activity
Ninomiya, J. T., Bi, Y., Banks, M. A., Lavish, S. A., Goldberg, V. M., & Greenfield, E. M. (1999) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100170109 · Cited by 7
Basic Biology of Bisphosphonates
Fleisch, H. A. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50017-9 · Cited by 7
Gibbs, M. A., & Tayal, V. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05472-0.00123-7 · Cited by 6
Bisphosphonate-related osteonecrosis of the jaw
Feller, L., Wood, N. H., Khammissa, R. A. G., Chikte, U. M. E., Bouckaert, M., & Lemmer, J. (2015) · Dental Abstracts · doi:10.1016/j.denabs.2015.07.037 · Cited by 6
Biology of Resorbable Bone Substitutes: CaP-Based and Polymers
Barbeck, M., Pissarek, J., Alkildani, S., Jung, O., & Unger, R. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-37234-6_17 · Cited by 5
Choi, A., Gang, H., Whang, J., & Gwak, H. (2010) · Drug Delivery · doi:10.3109/10717541003680999 · Cited by 5
Pharmacological and clinical properties of alendronate sodium hydrate.
Ohta, T., Komatsu, S., & Tokutake, N. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.120.409 · Cited by 5
Combination Therapy Using Exercise and Pharmaceutical Agents to Optimize Bone Health
Fuchs, R. K., & Warden, S. J. (2008) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-008-9017-3 · Cited by 5
“Loss of the ruffled border, combined with cytoskeleton disruption and the loss of osteoclast-unique actin rings, is sufficient to prevent bone resorption [34].”
BackgroundMechanisms of Action of Bisphosphonates as Inhibitors of Bone Resorption
Rogers, M. J., & Russell, R. G. G. (1996) · Medical intelligence unit · doi:10.1007/978-3-662-22505-9_7 · Cited by 5
Effective Pharmacotherapeutic Interventions for the Prevention of Hip Fractures
Bolognese, M. A. (2002) · The Endocrinologist · doi:10.1097/00019616-200201000-00008 · Cited by 5
Methods for studying cell death in bone
Boyce, B. F., Hughes, D. E., & Wright, K. R. (2007) · Springer eBooks · doi:10.1007/978-0-585-38227-2_5 · Cited by 5
Pamidronate - a promising new candidate for the management of spondyloarthropathy
Akerkar, S. M., & Bichile, L. S. (2005) · Indian Journal of Medical Sciences · doi:10.4103/0019-5359.16124 · Cited by 4
“Although these levels are unlikely to be attained by IV Pamidronate in blood, the levels of Pamidronate in the vicinity of resorbing bone are much higher; up to 10-3.[15] Alendronate has been shown to impair the antigen presenting function of the peripheral blood monocytes.”
BackgroundLee, J.-W., Jhee, O., Yuan, H.-D., Kim, T., Kim, D., Lee, M., Om, A., Lee, B.-Y., Park, S.-K., & Kang, J. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.369 · Cited by 3
“Al-endronate inhibits bone resorption via down-regulation of osteoclast formation, 3,4 suppression of osteoclast activation, inhibition of the activity of mature osteoclasts, 5 and induction of apoptosis of osteoclasts at the cellular level.”
Lee, S. Y., Kim, K. M., Kong, S. H., Oh, T. J., Moon, J. H., Choi, S. H., Lim, S. K., & Jang, H. C. (2016) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.2016.20.3.131 · Cited by 2
Histomorphometry of Remodeling and Modeling-Based Mineral Apposition
Li, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-5613-2_4 · Cited by 2
Fleisch, H. A. (1992) · Innovative Aspekte der klinischen Medizin · doi:10.1007/978-3-642-76708-1_9 · Cited by 2
A novel computational method to quantify and analyse osteoclastic bone resorption
Adamopoulos, I. E., & Pataridis, K. (2008) · Journal of Computational Methods in Sciences and Engineering · doi:10.3233/jcm-2007-7201 · Cited by 2
“Researchers employ different methods for counting the extent of bone resorption such as point counting [4] or image processing suites such as ADOBE and Image J which are not particularly suitable for such functions.”
Serum changes induced by intramedullar experimental administration of bisphosphonates.
ALMĂŞAN, H. A., Băciuț, G., Băciuț, M. F., Almăşan, O. C., Bran, S., & Oană, L. (2011) · PubMed · Cited by 2
Bisphosphonates: An Emerging Trend in Dentistry
Bains, V. K., Gupta, V., Singh, G., Patil, S. S., & Srivastava, R. (2011) · Asian Journal of Oral Health and Allied Sciences · doi:10.18231/j.ajohas.60238.1761912704 · Cited by 2
Improved titanium and steel implants : Studies on bisphosphonate, strontium and surface treatments
Linderbäck, P. (2011) · DiVA (Linkoping University) · Cited by 2
The effect of systemically and locally administered clodronate on bone quality
Rosenqvist, K. (2014) · Työväentutkimus Vuosikirja · Cited by 2
秀和, 小., 雅光, 川., & 熈, 加. (2000) · 日本歯周病学会会誌 · doi:10.2329/perio.42.267 · Cited by 2
Jang, E.-Y., Kown, H., Lee, C., Lee, C., & Lee, S.-H. (2001) · THE JOURNAL OF THE KOREAN ACADEMY OF PEDTATRIC DENTISTRY · Cited by 1
Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis
Radwan, I. A., Korany, N. S., & Ezzat, B. A. (2018) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2018.75030 · Cited by 1
“Where N-Bps cause disorganization of osteoclast cytoskeleton, affect osteoclast morphology, hinder the formation of ruffled border and prevents the formation of resorpative pits in vitro [40] and prevent intracellular transport of lysosomal enzymes to the basolateral surface of the cell, which is the normal site for t…”
BackgroundCellular and molecular actions of bisphosphonates
Munoz, M. A., & Rogers, M. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00025-6 · Cited by 1
Use of bisphosphonates in bone pathology – benefits and risks
Antonescu, D., & Stoica, C. I. (2023) · Romanian Journal of Rheumatology · doi:10.37897/rjr.2023.1.6 · Cited by 1
Ju-Hyun, P., Kum, K., Lee, J., Yu, J.-Y., & Lee, S.-J. (2001) · YUHSpace (Yonsei University Medical Library) · Cited by 1
Fleisch, H. A. (1994) · Springer eBooks · doi:10.1007/978-3-642-78596-2_12 · Cited by 1
Hayes, J., & Sambrook, P. N. (1996) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.5.12.1691 · Cited by 1
New insights into the mechanisms of bisphosphonates action
Tsetsenekou, E., & Kalyvas, D. (2010) · Cited by 1
Effects bisphosphonate(cimadronate) on osteoclasts in experimental periodontitis in hamsters.
Hasegawa, N. (1997) · Japanese Journal of Oral Biology · doi:10.2330/joralbiosci1965.39.43 · Cited by 1
Osteoporosis Therapy: Mechanistic Antiresorptives
Dodge, J. A., & Bryant, H. U. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc197.pub2 · Cited by 1
Bisphosphonate Inhibition of Prostate Cancer Cell Invasion, Migration and Cytoskeletal Organization
Virtanen, S. (2010) · UTUPub (University of Turku)
Osteoporosis Therapy: Mechanistic Antiresorptives
Dodge, J. A., & Bryant, H. U. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc197
Osteonecrosis caused by Bisphosphonates: a clinical case.
Spinelli, D., Vico, G. D., Bonino, M., Barlattani, A., Bollero, P., & Barlattani, A. (2009) · Europe PMC (PubMed Central)
Pompo, G. D. (2013) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/5361
Targeting the mevalonate pathway for pharmacological intervention
Tsoumpra, M. K. (2011) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-eonzejxmg
The Influence of Local Bisphosphonate Treatment on Implant Fixation
Jakobsen, T. (2008)
Valleala, H. (2005) · Helda - University of Helsinki Institutional Repository
Bisphosphonate effects upon relapse of orthodontically moved teeth
Osman, H., & Afify, A. K. (2006) · Egyptian Orthodontic Journal · doi:10.21608/eos.2006.79223
A case of IgD myeloma with renal failure and hypercalcemia.
Tsujimoto, Y., Tabata, T., Yamada, I., Shozi, S., Kishimoto, H., Inoue, T., Ishimura, E., Nishizawà, Y., & Morii, H. (1998) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.31.1207
Prevention and treatment of post-traumatic osteoarthritis
Park, M. (2016) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/1mgx-7864
Liposomal Bisphosphonates for the Treatment of Restenosis
Epstein-Barash, H., Afergan, E., Koroukhov, N., Eisenberg, G., Gutman, D., & Golomb, G. (2016) · CRC Press eBooks · doi:10.1201/9780849397271-14
Bioactive Ceramic Coatings for Metallic Implants
Moritz, N., Linderbäck, P., & Närhi, T. O. (2012) · CRC Press eBooks · doi:10.1201/b13049-5
The effects of biphosphonate use in the healing of hip fractures: A systematic review
Private Orthopaedic Surgeon, 2. S. S., & Begkas, D. G. (2016) · Journal of Frailty Sarcopenia and Falls · doi:10.22540/jfsf-01-017
“Osteoclasts are important for remodeling the callus into cortical bone, but biphosphonates inhibit osteoclast-mediated bone resorption in order to prevent bone loss and improve bone strength 34-36 .”
BackgroundA influência do uso dos bifosfonatos na Odontologia: revisão de literatura
Prearo, T. C. (2014) · UNESP Institutional Repository (São Paulo State University)
Role of Osteoclasts in potential pathogenic mechnism of ONJ
Kaur, K. (2015) · eScholarship (California Digital Library)
Exploring high dose effects of a bisphosphonate, HEBP, on osteogenesis in vitro
Girard, B. (2000) · TSpace (University of Toronto)
Lima, A. D. A. (2018) · OpenCommons at University of Connecticut (University of Connecticut)
Topical application of bisphosphonates to enhance alveolar new bone formation
Lozano‐Carrascal, N. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Periodontal management in osteoporosis patients
Awartani, F., Alzamil, A. F., & Alfada, S. A. (2019) · Oral Health and Care · doi:10.15761/ohc.1000167
Reszka, A. A., & Rodan, G. A. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00308-4
Reflected polarized darkfield imaging of bone surfaces
Sato, M., Herring, J., Kim, J., & Lilly, E. (1992) · Proceedings annual meeting Electron Microscopy Society of America · doi:10.1017/s0424820100129413
Self-citationPhytoestrogens and the control of osteoporosis
Lorenzetti, S., & Branca, F. (2004) · Elsevier eBooks · doi:10.1533/9781855739017.1.115
Fink, J. K. (2018) · Wiley eBooks · doi:10.1002/9781119510307.ch1
Raman Spectroscopic Investigation of Osteoclastic Activity under the Influence of Bisphosphonate
Marin, E., Adachi, T., Boschetto, F., Zhu, W., Adachi, K., Kanamura, N., Yamamoto, T., & Pezzotti, G. (2022) · Applied Sciences · doi:10.3390/app12083757
“Bisphosphonates also directly affect the capability of progenitor cells to differentiate into osteoblasts [16] while promoting their apoptosis [17], thus reducing the overall osteoclastic activity.”
BackgroundLiposomal Bisphosphonates for the Treatment of Restenosis
Epstein-Barash, H., Afergan, E., Koroukhov, N., Eisenberg, G., Gutman, D., & Golomb, G. (2006) · Informa Healthcare eBooks · doi:10.1201/9780849397271.ch10
Ethiraj, L. P. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/168636
Irnidayant, Y., Azzahra, M., Lusiyanti, Y., Tetriana, D., & Yusuf, D. (2024) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2024.276.282
Bisphosphonate-related osteoradionecrosis of the jaw
Choudhary, R., Reddy, S. S., Nagaraju, R., Kunjumon, S. P., Setia, S. S., & Sharma, R. S. (2023) · Saudi Journal of Oral Sciences · doi:10.4103/sjoralsci.sjoralsci_10_23
Jain, A., Hatwar, B., & Singhai, A. K. (2024) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.16.2.293-300
Effects of Soy Protein on Indices of Bone Turnover in Men and Women
Sinichi, N. (2000) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University)
Estudio macroscópico y del color en hueso humano sometido al calor con fines forenses
Díaz-Vico, R. (2024) · Repositorio Institucional de la Universidad de Málaga (University of Málaga)
Figueira, H. C. (2018) · Americanae (AECID Library)
Brüning, J. (2010) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)
Pan, B. (2002) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Garcia Júnior, N. A. (2011) · UNESP Institutional Repository (São Paulo State University)
Localized Osteolysis after Joint Replacement Surgery
Shanbhag, A. S., & Rubash, H. E. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3825-9_40
Metadata
- Authors
- Sato, M., & Grasser, W.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Sato, Masahiko
- ORCID
- Sato, Masahiko
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-01-01
- Volume
- 5
- Issue
- 1
- Pages
- 31-40
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1974903174
- Cited by
- 264
- References
- 35
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 5 · 2014: 6 · 2013: 1 · 2012: 6
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Merck Sharp and Dohme
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- bisphosphonates, osteoclasts, bone resorption, 1-hydroxyethane-1,1-diphosphonic acid, resorption pits, bisphosphonate toxicity, mechanism of action
- MeSH terms
- Pamidronate, Animals, Bone Resorption, Cattle, Cell Survival, Diphosphonates, Microscopy, Fluorescence, Microscopy, Phase-Contrast, Microscopy, Polarization, Osteoclasts, Rats, Inbred Strains, Etidronic Acid, Video Recording, Alendronate, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.